Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

11.1%

201 terminated/withdrawn out of 1819 trials

Success Rate

84.5%

-2.0% vs industry average

Late-Stage Pipeline

11%

195 trials in Phase 3/4

Results Transparency

44%

486 of 1097 completed trials have results

Key Signals

188 recruiting486 with results117 terminated84 withdrawn

Enrollment Performance

Analytics

N/A
768(53.1%)
Phase 2
287(19.8%)
Phase 1
161(11.1%)
Phase 4
118(8.2%)
Phase 3
77(5.3%)
Early Phase 1
35(2.4%)
1446Total
N/A(768)
Phase 2(287)
Phase 1(161)
Phase 4(118)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (1819)

Showing 20 of 1819 trials
NCT06347172Not ApplicableCompleted

Deprescribing in Patients Living With Dementia With Caregiver and Provider Nudges

Role: lead

NCT06281834Phase 1Recruiting

Dolutegravir Pharmacokinetics During Weekly Rifapentine/Isoniazid for TB Prevention

Role: lead

NCT01169259Phase 3Active Not Recruiting

Vitamin D and Omega-3 Trial (VITAL)

Role: lead

NCT07224776Phase 1Recruiting

Sparsentan for the Treatment of VEGF Signaling Pathway Inhibitor-Associated Proteinuria

Role: lead

NCT05069688Phase 1Recruiting

Dolutegravir Pharmacokinetics Among HIV/TB Coinfected Children Receiving Standard and High-dose Rifampicin

Role: lead

NCT03105518Phase 4Active Not Recruiting

Predictors of Postoperative Pain Following Oocyte Retrieval for Assisted Reproduction

Role: lead

NCT04416412Completed

ICG Fluorescence Imaging in Open Fracture Trauma Patients

Role: collaborator

NCT07053046Not ApplicableEnrolling By Invitation

PRECIDENTD Engagement Methods for Sites

Role: collaborator

NCT04263831Phase 1Recruiting

Low Dose IL-2 for the Treatment of Crohn's Disease

Role: collaborator

NCT07249840Phase 1Recruiting

Ropeginterferon for High Risk JAK2 Clonal Hematopoiesis

Role: lead

NCT04798469Phase 2Recruiting

Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism

Role: lead

NCT01339052Phase 2Completed

Phase II Study of BKM120 for Subjects With Recurrent Glioblastoma

Role: collaborator

NCT06135285Not ApplicableNot Yet Recruiting

A Device to Prevent Sudden Unexpected Death in Epilepsy: Detecting Peri-Ictal Body Position

Role: lead

NCT07724938Not ApplicableNot Yet Recruiting

Combination Tonsillectomy and Hypoglossal Nerve Stimulation for OSA Patients With Lateral Pharyngeal Collapse

Role: lead

NCT05144399Not ApplicableActive Not Recruiting

Accelerated Treatment of Endocarditis

Role: collaborator

NCT03851575Not ApplicableActive Not Recruiting

Accelerated Treatment of Endocarditis

Role: collaborator

NCT07278492Phase 1Not Yet Recruiting

NAD Augmentation to Prevent or Reverse Alzheimer's Disease in People With Down Syndrome

Role: lead

NCT07719049Recruiting

Artificial Intelligence-Based Health Assessment From Face Photographs - Healthy Volunteer Study

Role: lead

NCT07719062Not ApplicableNot Yet Recruiting

AI Chatbot for Prostate Radiation Therapy Patient Education

Role: lead

NCT05378399Phase 3Completed

SmartSteps: A Context-Aware, PrEP Adherence Intervention for Individuals With Substance Use Disorder

Role: lead